BridgeBio Pharma, Inc. — SEC Insider Profile, Roles & Companies

Insider transactions

05

0 buys (P) 0 sells (S) Net: $0 + 6 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

6 other filings hidden

Date	Ticker	Code	Shares	Price	Value	Owned after	Δ own	A/D
Jan. 26, 2021	1731831	P	14,428,836	·	·	1,000 Direct	·	Acquired
July 3, 2019	1731831	P	882,353	$29.90	$26,382,355	24,575,501 Indirect	+3.72%	Acquired
May 24, 2019	1731831	P	1,103,848	$25.93	$28,622,779	23,693,148 Direct	+4.89%	Acquired
Dec. 10, 2018	1731831	P	2,664	$13.96	$37,189	22,589,300 Direct	+0.01%	Acquired
Dec. 10, 2018	1731831	P	37,989	$13.29	$504,874	22,586,636 Direct	+0.17%	Acquired
Dec. 10, 2018	1731831	S	2,664	$13.96	$37,189	22,589,300 Direct	+0.01%	Acquired
Dec. 10, 2018	1731831	S	37,989	$13.29	$504,874	22,586,636 Direct	+0.17%	Acquired
Dec. 7, 2018	1731831	P	4,860	$14.36	$69,790	22,548,647 Direct	+0.02%	Acquired
Dec. 7, 2018	1731831	P	36,314	$13.94	$506,217	22,543,787 Direct	+0.16%	Acquired
Dec. 7, 2018	1731831	S	4,860	$14.36	$69,790	22,548,647 Direct	+0.02%	Acquired
Dec. 7, 2018	1731831	S	36,314	$13.94	$506,217	22,543,787 Direct	+0.16%	Acquired
Dec. 6, 2018	1731831	P	38,970	$13.34	$519,860	22,507,473 Direct	+0.17%	Acquired
Dec. 6, 2018	1731831	S	38,970	$13.34	$519,860	22,507,473 Direct	+0.17%	Acquired
Dec. 5, 2018	1731831	P	1,103,848	$14.01	$15,464,910	22,468,503 Direct	+5.17%	Acquired
Dec. 3, 2018	1731831	P	1,750,000	$15.50	$27,125,000	21,364,655 Direct	+8.92%	Acquired
June 22, 2018	1731831	C	12,832,123	·	·	0 Direct	-100.00%	Disposed
June 22, 2018	1731831	C	2,909,029	·	·	0 Direct	-100.00%	Disposed
June 22, 2018	1731831	X	332,262	·	·	2,909,029 Direct	+12.89%	Acquired
June 22, 2018	1731831	X	332,262	·	·	0 Direct	-100.00%	Disposed
June 22, 2018	1731831	P	1,000,000	$17.00	$17,000,000	19,614,655 Direct	+5.37%	Acquired
June 22, 2018	1731831	F	211,762	$17.00	$3,599,954	18,614,655 Direct	-1.12%	Disposed
June 22, 2018	1731831	C	18,826,417	·	·	18,826,417 Direct	·	Acquired

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06

Date	Ticker	Security	Underlying	Exercise price	Expiration	Shares	A/D
June 22, 2018	1731831	Series Seed Preferred Stock	Common Stock (15,347,219)	·	·	12,832,123	Disposed
June 22, 2018	1731831	Series B Preferred Stock	Common Stock (3,479,198)	·	·	2,909,029	Disposed
June 22, 2018	1731831	Series B Preferred Stock	Common Stock (397,385)	·	·	332,262	Acquired
June 22, 2018	1731831	Warrants	Series B Preferred Stock (332,262)	$10.83	·	332,262	Disposed

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

Date	Ticker	Security	Shares	Ownership
June 19, 2018	1731831	Series Seed Preferred Stock→ Common Stock (15,347,219)	15,347,219	Direct
June 19, 2018	1731831	Series B Preferred Stock→ Common Stock (3,081,813)	3,081,813	Direct
June 19, 2018	1731831	Warrants→ Series B Preferred Stock (332,262)	332,262	Direct